bit.bio
PrivateLast Round
Series C
Jan 9, 2026
Est. Valuation
$500M
Total Funding Raised
$228.92M
Company Overview
bit.bio is a synthetic biology company that specializes in creating consistent and functional human cells for advanced cell therapies, utilizing a patented gene-targeting approach to reprogram human induced pluripotent stem cells into specific, mature cell types for enhanced research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
bit.bio Comps
Public and private peers based on sector, stage, and business model.
bit.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 9, 2026 | ||||
| Series B Extension | Dec 16, 2024 | ||||
| Series B | Nov 5, 2021 | ||||
| Series A | Jun 13, 2020 | ||||
| Seed | Mar 27, 2019 | ||||
Seed | Nov 16, 2017 |
Key People
Founding team and executive leadership
bit.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlueYard Capital | Series A, Series B Extension |
| ARCH Venture Partners | Series B Extension, Series A |
| M&G Investments | Series C, Series B Extension |
| Foresite Capital | Series B, Series A |
| Puhua Capital | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Received Platinum status in the Green Impact Awards for the second consecutive year.
- Sep 9, 2025
Attended the 13th World Congress on Alternatives and Animal Use in the Life Sciences.
bit.bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about bit.bio's valuation, stock price, and market status.
